Quarterly Activities & Appendix 4C Cash Flow Reports
Filed with ASX ·
6ix is reading this filing.
Vectus Biosystems Limited on 6ix
Earlier from Vectus Biosystems
- FDA Pre-IND Meeting Request Granted for VB0004
- Placement of Shares
- Appointment of Dr Tara Speranza as CEO & CTO
- VB4-P5 Renal Compound Transaction Settled
- Half Year Report & Appendix 4D
Follow Vectus Biosystems into a list and get an email when it puts out news.
Follow Vectus Biosystems